Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-06-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1663 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|